Articles tagged with Cell Apoptosis
Scientists at the University of Groningen discovered how a folding protein cytochrome c interacts with mitochondria, leading to programmed cell death. The study found that cytochrome c is partly unfolded during this process, allowing for the regulation of cell death through drug development.
Research shows that relacorilant enhances paclitaxel-driven apoptosis in various cancer cell lines and xenograft models, providing a basis for its potential as an adjunct therapy. The study's findings support clinical benefits observed with relacorilant addition to paclitaxel-containing therapy in ovarian and pancreatic cancers.
Researchers found that damaged proximal tubule cells can promote disease progression by showing activity in genes that support survival and programmed cell death. These cells may contribute to the transition from acute to chronic kidney disease, affecting 9.1% of the world's population.
Extramitochondrial cytochrome C interacts with histone chaperone ANP32B to activate PP2A and facilitate DNA repair. In severe cases of DNA damage, cytochrome C triggers programmed cell death.
A new study reveals that coronaviruses induce substantial apoptosis in host cells, enabling their internal spread. Targeting this process with PERK inhibitors reduces viral pathogenesis and lung damage.
Researchers discovered that hydraulic instability amplifies small volume differences between germ cells, leading to their selection for growth or shrinkage. The study reveals a mechanical mechanism governing the life and death decision in the nematode germline.
Research reveals STAT3 induces GLI1 expression in chronic lymphocytic leukemia cells, a finding that may lead to therapeutic interventions. GLI1 overexpression is associated with survival advantage in CLL, and its inhibition by specific compounds could increase cell death.
MIT biologists discovered that cells are squeezed out of tissue when they can't replicate their DNA during cell division. This process, called extrusion, may serve as a way to eliminate cancerous or precancerous cells.
Researchers developed nanobodies that target a protein making Ehrlichia chaffeensis bacteria infectious. In mice experiments, the treatment showed significantly lower levels of bacteria two weeks after infection.
New study reveals that N-terminal acetylation shields proteins from degradation and inhibits programmed cell death, opening up new approaches for cancer therapy. IAPs play a wider role in protein quality control, recognizing defective proteins for destruction, and triggering apoptosis in tumor cells.
This study elucidates the molecular mechanism of 2-methoxyestradiol (2MeOE2) inducing apoptosis in ovarian tumors through PKCδ signaling. The findings suggest that 2MeOE2 activates PKCδ, leading to γH2Ax expression and apoptotic histone modifications, thereby driving apoptosis in ovarian cancer cells.
Researchers found that Mind bomb-2 (MIB2) ubiquitinates and stabilizes the anti-apoptotic protein cFLIP, preventing excessive cell death. This discovery may lead to new therapeutic strategies for treating cancers and neurodegenerative diseases.
Researchers at UCL developed a pioneering new eye test called DARC that can predict wet age-related macular degeneration (AMD) three years before symptoms appear. The test uses a fluorescent dye to detect stressed retinal cells, which then predicts future AMD activity.
Researchers found that selective pruning of key brain connections in the developing mouse visual cortex clears a path for certain pyramidal neurons to be more active. This process allows for faster communication between the two visual hemispheres, enabling binocular vision and depth perception.
Chronic graft-versus-host disease (cGVHD) causes skin thickening due to the production of TGFβ1 by apoptotic keratinocytes stimulated by interferon-γ, according to researchers at the University of Tsukuba.
Researchers at Kumamoto University found that mild electrical stimulation with heat shock reduces inflammation and cell death in the kidneys, improving kidney function and preventing proteinuria. The treatment also inhibits apoptosis of kidney cells and activates survival pathways, offering a promising new approach for treating nephrot...
Researchers have identified two key factors involved in cellular recovery from extreme stress, which may provide new strategies for treating cancers. The study reveals that apoptosis is a more nuanced process than previously known, and sometimes cells survive the executioner caspase via anastasis.
Scientists have created a light-activated chemical inhibitor that can control two fundamental cellular processes: cell division and cell death. This innovation has significant implications for studying cellular functions, understanding medical disorders, and designing new therapeutic strategies.
This study examines the effects of talc on mesothelial and neoplastic cells, revealing high levels of IL-6 and TNFRI. The results suggest that normal mesothelium is the main stimulus for the inflammatory process, with talc inducing higher rates of apoptosis in neoplastic cells.
Scientists discover that stressed liver cells quickly become senescent after hemorrhagic shock, a condition that accounts for 30-40% of trauma-related deaths. This rapid transition to senescence may help prevent organ failure, but drugs targeting senescent cells can be lethal in the context of injury.
Researchers have identified the cellular process by which Cisplatin chemotherapy causes neuronal damage, revealing that it induces senescence of peripheral neurons through overexpression of the p21 protein. This discovery provides new targets for neuroprotective treatments to alleviate or avoid the adverse effects of Cisplatin.
Lymphoma cells can resist therapy by evading apoptosis due to the presence of the Livin protein. Targeting Livin using inhibitors may be effective in refractory cases. Researchers have identified a promising immunotherapeutic strategy by combining CD40-mediated Fas expression with specific targeting of Livin.
A new study found that a protein called BIK triggers failed apoptosis, leading to DNA damage and mutations in ER-positive breast cancer cells. This process makes the cancer cells more aggressive and evasive of therapy.
Researchers discovered Shigella's molecular strategy to disarm host cell protective mechanisms, including apoptosis and necroptosis. By blocking apoptosis with OspD3 and activating necroptosis with OspC1, Shigella ensures its survival and proliferation.
Researchers at Monash University have discovered a previously unknown way bacteria evade immune responses, targeting mitochondria for disarming. The study suggests potential new ways to combat resistant bacterial infections and could lead to new therapeutic possibilities.
The COVID-19 virus acts as a microRNA sponge, depleting specific miRNAs that regulate cell metabolism and stress responses. This depletion promotes infected cell survival, allowing the virus to replicate and evade the host's immune system.
Researchers have identified a single gene, SLC20A1, that controls the development of excretory organs and genitalia. Mutations in this gene can cause severe developmental disorders, including bladder exstrophy epispadias complex.
A research team led by Sika Zheng identifies a mechanism that prevents death of neurons, which is triggered at neuron birth and is crucial for maintaining neural circuit integrity. The study challenges the notion that neuronal survival is determined extrinsically.
Researchers found that BI-D1870 inhibits AML cell proliferation and increases G2/M population without affecting CDC2 and CDC25C. The combination of BI-D1870 and vincristine synergistically increases mitotic arrest and apoptosis in AML cells, providing a promising novel approach to overcoming resistance.
A recent study published in Scientific Reports found that silicone molecules from breast implants can initiate processes leading to cell death in human cells. The researchers used cultured cells and observed similarities with programmed cell death, which may have implications for the health effects of silicone breast implants.
Scientists from Tokyo University of Science successfully synthesized a new compound that can reactivate the self-destruct gene in cancer cells, offering a potential new treatment option for patients with colorectal cancer. The team's breakthrough could lead to improved outcomes and quality of life for patients with this devastating dis...
Researchers have identified key changes in a molecular pathway that plays critical roles in human development, blood pressure regulation, inflammation, and cell death. The findings provide a blueprint for drug development and shed light on how common medications interact with the target.
Piya Ghose, an assistant professor of biology at UTA, has established a new lab with $2 million in CPRIT funding. Her research focuses on programmed cell death, which can lead to cancer through tumor creation. Ghose's work aims to understand how tumors behave throughout the body and could lead to breakthroughs in cancer treatment.
Researchers found that p53 plays a crucial role in regulating cell division and apoptosis only during pluripotent stem cell differentiation, resolving years of conflicting results. The study used various chemotherapy drugs to induce apoptosis in ESCs and showed that p53 is not essential for cell cycle arrest or apoptosis prior to diffe...
James L. Kirkland, MD, PhD, received the Irving S. Wright Award for his research on cellular senescence and age-related diseases, while Sean Curran, PhD, won the Vincent Cristofalo Rising Star Award for his work on aging biology. Both awards recognize their contributions to advancing our understanding of aging.
A new AI-supported test, called DARC, can detect glaucoma progression 18 months earlier than the current gold standard method. The technology involves injecting a fluorescent dye into the bloodstream and illuminating damaged retinal cells using artificial intelligence.
Researchers from Skoltech have made significant progress in understanding the apoptotic program, a crucial process for removing unneeded or abnormal cells. The study has identified key proteins involved in this process, which could lead to new therapeutic targets for treating cancer.
Bayreuth geneticists have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cells. The separase enzyme plays a central role in this process and can be re-purposed to induce apoptosis in cancer cells.
Scientists at Forschungsverbund Berlin found that anti-oxidative enzymes, particularly SOD2, contribute to the unusual longevity of the corpus luteum in lynxes. This discovery provides important insights into lynx reproduction and may support conservation breeding programs.
Researchers have developed a simple method to prepare 3D keratin scaffold models that mimic the structure and biological function of native extracellular matrix. The study demonstrates the ability of cells to grow on these scaffolds without morphological changes or apoptosis, making them promising candidates for tissue engineering.
A direct link has been found between the anti-apoptotic BCL2-family protein MCL1 and the cell-cycle checkpoint protein P18, showing that MCL1 can initiate cell proliferation via the CDK4/6-RB pathway.
Researchers at the University of Trento identified a new molecular mechanism that determines the fate of cancer cells. The 'switch' protein DHX30 regulates p53's response to treatment, leading to either cell cycle arrest or programmed cell death, with potential applications for solid tumors in the colon, breast, and lung.
Researchers at Tohoku University discovered that certain trans fats can trigger programmed cell death by activating a mitochondrial signaling pathway. This finding has significant implications for understanding the role of trans fats in diseases such as atherosclerosis and neurodegenerative disorders.
Researchers found that inhibiting apoptosis in fruit fly neurons led to the development of 'zombie' cells that formed new olfactory neuron networks with distinct properties. These neurons expressed different receptors, including those for carbon dioxide detection, giving the flies enhanced odor perception.
In a study published in PLOS Genetics, researchers found that the NCBP2 gene acts as a key modifier, influencing the impact of other genes in a large genetic deletion. This suggests that neurodevelopmental disorders, such as schizophrenia and autism, result from complex interactions among multiple genes rather than individual genes.
A WPI researcher has received a $154,000 grant to investigate the relationship between programmed cell death and calcium deposits in heart tissue that cause aortic valve failure. The study aims to discover ways to interrupt the process leading to calcification and potentially develop treatments to stop it.
The study reveals syndecan-4's role in sensing environmental conditions outside cells, driving cellular processes behind cancer and diseases. Activating these cellular 'hands' triggers a pathway involving YAP, controlling apoptosis and blood vessel development.
Certain bacteria, such as Shigella, use lipopolysaccharides to block caspases and prevent apoptosis, allowing them to multiply intracellularly. This strategy is essential for their survival and spread within the human body.
Researchers discovered an alternate mechanism by which the molecule RIPK1 triggers cell death in infected or damaged cells. The finding breaks existing dogma that RIPK1 kinase activity is required for cell death and holds promise for treating inflammatory diseases and cancer.
Researchers found luteolin suppresses both early stage prostate carcinogenesis and CRPC by inducing apoptosis. MicroRNA-8080 (miR-8080) recruited by luteolin down-regulates AR-V7, inhibiting tumorigenesis and enzalutamide resistance in CRPC.
A new study reveals that caspase-8 controls multiple cell death mechanisms, including pyroptosis, apoptosis, and necroptosis. The research found that the enzymatic activity of caspase-8 is required to inhibit pyroptosis, while inactive caspase-8 induces pyroptosis when necroptosis is blocked.
Researchers have identified HIPK2 as a novel regulator of heart failure progression. The kinase was found to play a critical role in maintaining cardiac function, with its deletion leading to progressive deterioration and apoptosis in heart muscle cells.
Researchers at Tokyo University of Agriculture and Technology discovered that hybrid plant cells induce programmed cell death due to protein aggregate accumulation. The study used imaging tools and a chemical chaperone to halt the process, paving the way for genetic improvement techniques to enhance crop varieties' disease resistance a...
A new compound has been developed that can prevent unwanted cell death, which could improve recovery from medical emergencies and procedures. The study's findings suggest the potential for using this 'cell death blocker' to treat conditions like cardiovascular diseases and degenerative disorders.
Parkinson's disease is a neurodegenerative disorder characterized by motor and cognitive impairments. Scientists listed ways of applying genetic engineering to study and treat the disease, including manipulating mitochondria and iron homeostasis. CRISPR technology holds promise for finding new effective treatments.
A new mechanism was discovered that induces programmed cell death in cancer cells by disrupting ion homeostasis, leading to increased reactive oxygen species and endoplasmic reticulum stress. This approach has been shown to strongly inhibit tumor growth in animal models.
Researchers found that chronic stress leads to autophagic death of adult hippocampal NSCs, causing decline in adult neurogenesis. Deleting Atg7 or SGK3 gene prevents cell death and maintains normal brain functions.
Scientists from Tokyo University of Science have discovered exactly how cell-free DNA (cfDNA) is generated, revealing its crucial role in tumor progression. The study's findings suggest that cfDNA can be targeted using DNase1L3, a novel molecule to prevent tumor metastasis and thrombosis.
In the absence of gasdermin D, caspase-1 induces apoptosis, but not pyroptosis, in macrophages. Caspase family members caspase-3 and caspase-9 are involved in this process. The study suggests that caspase-1 activates Bid, a pro-apoptotic protein, which induces cytochrome c release from mitochondria and subsequent apoptosis.
A new biomarker, TP53INP2, has been identified as a potential marker for personalized cancer treatments. This protein increases the sensitivity of cancer cells to death signals, such as TRAIL, enhancing the efficacy of chemotherapy treatments.